Tiger Woods’ career ended after he bulked up

April 10, 2015- By Steven E. Greer, MD

Ten years ago, Tiger Woods hit one of the most memorable shots in golf when he chipped in a birdie on the 16th hole at Augusta in the Read more »

What Steve Jobs would have invented if he had lived longer

Update January 29, 2014- Apple posted Q4 earnings so big that they are incomprehensible. Read more »

Paul Richardson, MD: Current Therapies for Multiple Myeloma

Interviewed by Steven Greer, MD

Dr. Paul Richardson, Clinical Director of the Multiple Myeloma Center at Harvard’s Dana-Farber Cancer Institute gives an overview of the current standard of care for patients with multiple myeloma

Cardiology genomic, stem cell, and interventional research at U. Miami

The Healthcare Channel hosted, in conjunction with Mark Schoenebaum of ISI, a tour of the University of Miami medical center campus. A panel of world leaders in cardiology gave an overview of the latest in stem cell regeneration of myocardial infarction, genomics, and interventional procedures.

In Part 1, Dean Goldschmidt introduces the faculty.

In Part 2, Dr. O’Neill leads of the discussion with an overview of research at Miami.

New Therapies to treat acute spinal cord injury

Interviewed by Steven Greer, MD

W. Dalton Dietrich, Ph.D., Scientific Director of the Miami Project to Cure Paralysis discusses two therapies to treat acute spinal cord injury (SCI). First, he discusses the trial recently allowed to proceed by the FDA, funded by company Geron, to use stem cells to treat SCI. It will be the first human trial of its kind in the U.S. In the second part of the interview, he discusses the pioneering work from Miami that uses hypothermia to treat acute SCI.

Joshua Hare, MD: Stem cells to repair myocardial infarcts

August 12, 2010

Interviewed by Steven Greer, MD

Dr. Joshua Hare, Director of the Interdisciplinary Stem Cell Institute, University of Miami Health System, discusses a recent study published testing stem cells to repair myocardial infarcts. They used a porcine infarct model to follow mesenchymal stem cells injected into MI’s. The infarct areas diminished and heart function improved. Moreover, the stem cells seemed to be the cause for the recovery rather than nonspecific inflammation.